{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:16:49Z","timestamp":1778221009590,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lower respiratory tract infections (LRTIs) are major health problem worldwide. Accurate pathogen identification using conventional microbiological tests (CMTs) is challenging. Targeted next-generation sequencing (tNGS) is a promising diagnostic approach; however, its performance compared with that of CMTs, and its impact on patient outcomes require further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study enrolled 562 patients with suspected lower respiratory infections from 29 departments during 2023\u20132025. Bronchoalveolar lavage fluid samples from all patients underwent parallel testing with both tNGS and CMTs. The primary outcomes were pathogen detection rates (tNGS vs. CMTs), turnaround time, and clinical outcomes. Secondary outcomes comprised antibiotic modification rates, length of hospital stay, 28-day mortality, and intensive care unit admission rates. Multivariable logistic regression and propensity score adjustment were used to assess the independent impact of tNGS-guided therapy on patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The pathogen detection rate was significantly higher with tNGS than with CMTs (89.5% vs. 62.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001; McNemar test). tNGS was more sensitive than CMTs for detecting special pathogens (36.8% vs. 8.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), viruses (83.5% vs. 18.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), and fungi (73.5% vs. 31.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Among 314 patients with tNGS-adopted management, 68.8% received antibiotic modifications. In the adjusted analysis, tNGS-guided therapy was associated with a reduced length of hospital stay (adjusted\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22122.3\u202fdays,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.003) and lower 28-day mortality (adjusted odds ratio: 0.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.032).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>tNGS is more sensitive than CMTs at detecting all categories of pathogens and when results are used to guide clinical management, tNGS is associated with improved clinical outcomes including reduced mortality and shorter hospital stays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1802040","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:52:37Z","timestamp":1778219557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative study of targeted next-generation sequencing and traditional pathogen detection methods in lower respiratory tract infections: impact on patient outcomes"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhengyuan","family":"An","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]},{"name":"Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirong","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, People's Hospital of Dejang","place":["Tongren, Guizhou, China"]},{"name":"Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S416","DOI":"10.1093\/cid\/ciaa1516","article-title":"Clinical utility of in-house metagenomic next-generation sequencing for the diagnosis of lower respiratory tract infections and analysis of the host immune response","volume":"71","author":"Chen","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"950531","DOI":"10.3389\/fcimb.2022.950531","article-title":"Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in pediatric pneumonia","volume":"12","author":"Deng","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2021.09.012","article-title":"Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections","volume":"38","author":"Diao","year":"2022","journal-title":"J. Adv. Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1578939","DOI":"10.3389\/fcimb.2025.1578939","article-title":"Comparison of the diagnostic capabilities of tNGS and mNGS for pathogens causing lower respiratory tract infections: a prospective observational study","volume":"15","author":"Ding","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1549044","DOI":"10.3389\/fmicb.2025.1549044","article-title":"Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods","volume":"16","author":"Elbehiry","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"001567","DOI":"10.1099\/mic.0.001567","article-title":"Microbial primer: challenges and opportunities in the treatment of chronic polymicrobial infections\u2013an eco-evolutionary perspective","volume":"171","author":"Farrell","year":"2025","journal-title":"Microbiology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1186\/s12879-025-12152-2","article-title":"HIV infection complicated with talaromyces marneffei, tuberculosis, hemophagocytic lymphohistiocytosis and non-Hodgkin lymphoma: a complex case report","volume":"25","author":"Fu","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12931-024-02887-y","article-title":"A single-center, retrospective study of hospitalized patients with lower respiratory tract infections: clinical assessment of metagenomic next-generation sequencing and identification of risk factors in patients","volume":"25","author":"Gao","year":"2024","journal-title":"Respir. Res."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e00526-22","DOI":"10.1128\/jcm.00526-22","article-title":"Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens","volume":"60","author":"Gaston","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1653424","DOI":"10.3389\/fphar.2025.1653424","article-title":"Antibiotic-sparing strategies for multidrug-resistant organism (MDRO) infections","volume":"16","author":"Geng","year":"2025","journal-title":"Front. Pharmacol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1271952","DOI":"10.3389\/fcimb.2023.1271952","article-title":"Clinical utility of metagenomic next-generation sequencing in pathogen detection for lower respiratory tract infections and impact on clinical outcomes in southernmost China","volume":"13","author":"Hao","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tim.2024.06.005","article-title":"Cell-free DNA: a promising biomarker in infectious diseases","volume":"33","author":"Hu","year":"2025","journal-title":"Trends Microbiol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0312724","DOI":"10.1128\/spectrum.03127-24","article-title":"Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance when applied in paucibacillary clinical samples","volume":"13","author":"Jin","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1517772","DOI":"10.3389\/fmicb.2025.1517772","article-title":"Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions","volume":"16","author":"Karnwal","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/CCM.0000000000002924","article-title":"Culture-negative septic shock compared with culture-positive septic shock: a retrospective cohort study","volume":"46","author":"Kethireddy","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1494638","DOI":"10.3389\/fcimb.2025.1494638","article-title":"The application prospect of metagenomic next-generation sequencing technology in diagnosing suspected lower respiratory tract infections","volume":"15","author":"Li","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ijid.2022.07.060","article-title":"Metagenomic next-generation sequencing for accurate diagnosis and management of lower respiratory tract infections","volume":"122","author":"Liang","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12879-022-07381-8","article-title":"Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/S2666-5247(23)00031-9","article-title":"Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study","volume":"4","author":"Liu","year":"2023","journal-title":"Lancet Microbe."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"001808","DOI":"10.1099\/jmm.0.001808","article-title":"Improving pulmonary infection diagnosis with metagenomic next-generation sequencing of bronchoalveolar lavage fluid","volume":"73","author":"Long","year":"2024","journal-title":"J. Med. Microbiol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s15010-024-02185-1","article-title":"Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice","volume":"52","author":"Lv","year":"2024","journal-title":"Infection"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/cid\/ciw787","article-title":"Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings","volume":"64","author":"Moehring","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1451440","DOI":"10.3389\/fcimb.2024.1451440","article-title":"Comparative analysis of metagenomic and targeted next-generation sequencing for pathogens diagnosis in bronchoalveolar lavage fluid specimens","volume":"14","author":"Sun","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref25","volume-title":"WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis\u2013Rapid Diagnostics for Tuberculosis Detection","year":"2024"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1590881","DOI":"10.3389\/fcimb.2025.1590881","article-title":"Application of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections","volume":"15","author":"Xu","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"107440","DOI":"10.1016\/j.ijantimicag.2024.107440","article-title":"Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: a systematic review and meta-analysis","volume":"65","author":"Yan","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/THC-240823","article-title":"Bronchial lavage tNGS in the diagnosis of pulmonary tuberculosis","volume":"33","author":"Yang","year":"2025","journal-title":"Tech Health Care"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1493915","DOI":"10.3389\/fcimb.2025.1493915","article-title":"Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review","volume":"15","author":"Yarahmadi","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1097\/BRS.0000000000005148","article-title":"Pathogenic detection by metagenomic next-generation sequencing in spinal infections","volume":"50","author":"Yin","year":"2025","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"105307","DOI":"10.1016\/j.ebiom.2024.105307","article-title":"Enhancing lower respiratory tract infection diagnosis: implementation and clinical assessment of multiplex PCR-based and hybrid capture-based targeted next-generation sequencing","volume":"107","author":"Yin","year":"2024","journal-title":"EBioMedicine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"03000605221089795","DOI":"10.1177\/03000605221089795","article-title":"Application of metagenomic next-generation sequencing for bronchoalveolar lavage diagnostics in patients with lower respiratory tract infections","volume":"50","author":"Zhang","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s15010-025-02520-0","article-title":"Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study","volume":"53","author":"Zhao","year":"2025","journal-title":"Infection"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12890-024-03237-w","article-title":"Clinical utility of metagenomic next-generation sequencing on bronchoalveolar lavage fluid in diagnosis of lower respiratory tract infections","volume":"24","author":"Zheng","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"694756","DOI":"10.3389\/fcimb.2021.694756","article-title":"The diagnostic value of metagenomic next-generation sequencing in lower respiratory tract infection","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fcimb.2019.00351","article-title":"Clinical evaluation of diagnosis efficacy of active Mycobacterium tuberculosis complex infection via metagenomic next-generation sequencing of direct clinical samples","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1802040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:52:38Z","timestamp":1778219558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1802040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":36,"alternative-id":["10.3389\/fmicb.2026.1802040"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1802040","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1802040"}}